Genomics in Precision Medicine From Biological Code to Clinical Insight

For  almost 20 years, custom medicine’s potential for success has been driven by the ability to potentially identify molecular signatures for a disease’s etiology instead of population-based markers. Currently, the molecular signatures of diseases have the potential to positively integrate a multitude of technological, biological, and computational advancements, and transform the field of genomics from the research phase to practical, real-world clinical applications in oncology, neonatal medicine, rare diseases, and pharmacogenomics.

Advances have enabled the field to develop an ecosystem with next-generation sequencing (NGS), functional genomics, pangenomics,…